Hinge Health (HNGE) director receives 9,896 restricted stock units in equity grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Sloat Tyler reported acquisition or exercise transactions in this Form 4 filing.
Hinge Health, Inc. director Tyler Sloat received an award of 9,896 shares of Class A Common Stock as a grant, reported at a price of $0.00 per share. After this transaction, he directly holds 9,896 shares.
The filing explains that these 9,896 shares are restricted stock units (RSUs), which vest in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of Class A Common Stock, so the actual share delivery depends on future vesting conditions.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Sloat Tyler
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 9,896 | $0.00 | -- |
Holdings After Transaction:
Class A Common Stock — 9,896 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Hinge Health (HNGE) report for Tyler Sloat?
Hinge Health reported that director Tyler Sloat acquired 9,896 shares of Class A Common Stock through a grant. The transaction was coded as an award, not a market purchase, and carried a reported price of $0.00 per share.
What type of equity did Hinge Health (HNGE) grant to Tyler Sloat?
Hinge Health granted 9,896 restricted stock units (RSUs) to director Tyler Sloat. The footnote states each RSU represents a contingent right to receive one share of Class A Common Stock, vesting according to the terms of the award agreement.